Related Funds
Fund Name | Location |
Carleton Advisors | Cleveland, Ohio, United States |
Dingli Communications | China, Guangdong, Zhuhai |
Global Grand Capital | - |
IBG Risikokapitalfonds II GmbH & Co. KG | - |
Jiankun Investment | Beijing, Beijing, China |
Jisu Ziben | China, Hangzhou, Zhejiang |
Kehui Venture Capital | China, Shanghai |
Kelly Gamma | - |
Lotus Venture Capital | Chaoyang, China, Liaoning |
M31 Italia Srl | Italy, Padova, Veneto |
Maxima Capital Management | Taipei, Taiwan |
Quantum Leaps Corporation | Chiyoda, Japan |
Rezayat Investments | England, London, United Kingdom |
Smart Lenders Asset Management Ltd | England, London, United Kingdom |
SVG Media | Gurgaon, Haryana, India |
Tarsadia Investments | California, Newport Beach, United States |
TMT Connekt | Dubai, United Arab Emirates |
Triton Funds LLC | California, Los Angeles, United States |
Verso Capital | Belgium, Luxembourg, Luxembourg |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ASLAN Pharmaceuticals | $34M | 07 Dec 2015 | Singapore, Central Region, Singapore | ||
ASLAN Pharmaceuticals | $22M | 10 Oct 2013 | Singapore, Central Region, Singapore | ||
TransMedics | $29M | 14 Mar 2006 | Massachusetts, United States | ||
Presidio Pharmaceuticals | 01 Mar 2006 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ASLAN Pharmaceuticals | $34M | 07 Dec 2015 | Singapore, Central Region, Singapore | ||
ASLAN Pharmaceuticals | $22M | 10 Oct 2013 | Singapore, Central Region, Singapore | ||
TransMedics | $29M | 14 Mar 2006 | Massachusetts, United States | ||
Presidio Pharmaceuticals | 01 Mar 2006 | San Francisco, California, United States |